Where does Schott Pharma AG & Co. Kgaa rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Schott Pharma AG & Co. Kgaa ranks #13,143 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Schott Pharma AG & Co. Kgaa hold?

Schott Pharma AG & Co. Kgaa holds 23 US utility patents granted between 2023 and 2025, spanning 16 technology areas.

What is Schott Pharma AG & Co. Kgaa's Innovation Score?

Schott Pharma AG & Co. Kgaa has an Innovation Score of 56.2 out of 100 (top 6% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Schott Pharma AG & Co. Kgaa's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Schott Pharma AG & Co. Kgaa.

What does claim depth mean for Schott Pharma AG & Co. Kgaa's patents?

Schott Pharma AG & Co. Kgaa's patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Schott Pharma AG & Co. Kgaa patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Schott Pharma AG & Co. Kgaa

Q: What technology areas does Schott Pharma AG & Co. Kgaa focus on?

Schott Pharma AG & Co. Kgaa's top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 14 patents, ranking #66 of 903 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 23 granted patents across 16 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Schott ranks #13,143 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 16 technology areas.

#13,143
of 49,997 US assignees by volume: Top 6%
by Innovation Score (56.2/100): 18.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R13143 · Foreign Corporation #13,143 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 23 grants
MID-PACK #13,143/49,997
PHOTO-FINISH Roswell Biotechnolog…
CPC-FOCUS A61J · 16 areas
INNOV-PAR 56.2/100
CLAIMS-RICH 18.5 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Roswell Biotechnologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Schott’s 56.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.0 pts (20%) Velocity 20.0 pts (36%) Breadth 14.1 pts (25%) Claim depth 11.1 pts (20%)

Qualcomm Incorporated · highest

85
Schott Pharma & Kgaa · this assignee

56
3D Lighting… · lowest

7

What this shows Schott's Innovation Score is 56.2/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Schott?

Each dot is one of Schott’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Schott’s own 18.5 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Schott vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Schott's grants concentrate

Schott Pharma AG & Co. Kgaa is a focused PatentsView assignee: 16 CPC subclasses with 60.9% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). By volume, Schott sits between Roswell Biotechnologies, Inc. and Serta, Inc..

Schott's three-year grant acceleration

Schott Pharma AG & Co. Kgaa shows 16 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Roswell Biotechno…

23
Saint-gobain Cris…

23
Samhwa

23
Schott Glass (Suz…

23
SEA Sonic

23
Sensory Incorpora…

23
Sentinel Connecto…

23
Serta

23
Schott Pharma & K… ◀

23

What this shows Schott holds 23 patents at rank #13,133, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Schott

By rank, the assignees closest to #13,133 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Schott's primary technology class.

Schott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Schott Pharma AG & Co. Kgaa patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	8	34.8%
2024	8	34.8%
2025partial year	7	30.4%

Which technologies does Schott Pharma AG & Co. Kgaa patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 14

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 8

C03B - Manufacture, Shaping, OR Supplementary Processes 7

C03C - Chemical Composition OF Glasses, Glazes OR Vitreous ENAMELS; Surface Treatment OF GLASS; Surface Treatment OF Fibres OR Filaments Made From Glass, Minerals OR SLAGS; Joining Glass TO Glass OR Other Materials 4

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 2

C10M - Lubricating Compositions ; USE OF Chemical Substances Either Alone OR AS Lubricating Ingredients IN A Lubricating Composition 2

C10N - Indexing Scheme Associated With Subclass C10m Relating TO Lubricating Compositions 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 2

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 1

B41M - Printing, Duplicating, Marking, OR Copying PROCESSES; Colour Printing, 1

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Schott Pharma AG & Co. Kgaa's patent record in context - here's where to go next.

Schott Pharma AG & Co. Kgaa's lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 60.9% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #13,143 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Schott Pharma AG & Co. Kgaa against Roswell Biotechnologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 56.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.